Congenica, GenomOncology Announce Collaborative Agreement at AMP

News   Nov 05, 2015

 
Congenica, GenomOncology Announce Collaborative Agreement at AMP
 
 
 

RELATED ARTICLES

CRISPR Rescues Fragile X Syndrome Neurons

News

The gene editing technology CRISPR has been used to restore normal activity in neurons affected by Fragile X Syndrome.

READ MORE

High-throughput Screening: Microscale Thermophoresis to Characterize Hits

News

A new perspective article details how the European Lead Factory (ELF), a large publicly accessible drug discovery platform, uses microscale thermophoresis (MST) to aid in the prioritization of small molecule hits from high-throughput screening.

READ MORE

Sequencing Shows How Evolution Can Undermine Bioprocess Commercialization

News

Rapid evolution can suppress the effect of pro-production genes in biochemical processes.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE